Skip to main content

Table 3 Number of eligible patients and number of times a selected procedure was performed in eligible patients.

From: Payment for performance (P4P): any future in Italy?

 

Hospital N.1

Hospital N.2

Hospital N.3

 

N. of times the selected procedure is performed in eligible patients

N. of eligible patients

N. of times the selected procedure is performed in eligible patients

N. of eligible patients

N. of times the selected procedure is performed in eligible patients

N. of eligible patients

1. Aspirin prescribed at discharge

390

460

323

345

262

305

2. Beta-blocker prescribed at discharge

376

460

249

345

200

305

3. Adult smoking cessation advice/counseling

16

139

  

2

46

4. LDL cholesterol assessment

73

460

48

345

1

305

5. Lipid lowering therapy at discharge

376

460

256

345

219

305

6. Inpatient mortality

38

498

    

7. Evaluation of left ventricular systolic (LVS) function (LVF Assessment)

1049

1590

663

1277

314

575

8. ACEI or ARB for left ventricular systolic dysfunction (LVSD)

1059

1590

909

1277

352

575

9. Adult smoking cessation advice/counseling

22

145

  

6

33

10. Thrombolytic therapy administered

15

347

6

420

0

172

11. Discharged on cholesterol reducing medication

74

347

174

420

37

172

12. Smoking cessation advice/counseling

4

33

  

8

10

13. Recommended Venous Thromboembolism (VTE) Prophylaxis Ordered

169

182

0

533

24

200